Acute Cerebrovascular Events With COVID-19 Infection

Authors

Mandip S. Dhamoon, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Alison Thaler, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Kapil Gururangan, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Amit Kohli, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Daniella Sisniega, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Danielle Wheelwright, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Connor Mensching, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Johanna T. Fifi, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Michael G. Fara, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Nathalie Jette, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Ella Cohen, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Priya Dave, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Aislyn C. DiRisio, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Jonathan Goldstein, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Emma M. Loebel, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Naomi A. Mayman, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Akarsh Sharma, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Daniel S. Thomas, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Ruben D. Vega Perez, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Mark R. Weingarten, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Huei Hsun Wen, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Stanley Tuhrim, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.
Laura K. Stein, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York.

Document Type

Article

Abstract

BACKGROUND AND PURPOSE: Coronavirus disease 2019 (COVID-19) has been associated with an increased incidence of thrombotic events, including stroke. However, characteristics and outcomes of COVID-19 patients with stroke are not well known. METHODS: We conducted a retrospective observational study of risk factors, stroke characteristics, and short-term outcomes in a large health system in New York City. We included consecutively admitted patients with acute cerebrovascular events from March 1, 2020 through April 30, 2020. Data were stratified by COVID-19 status, and demographic variables, medical comorbidities, stroke characteristics, imaging results, and in-hospital outcomes were examined. Among COVID-19-positive patients, we also summarized laboratory test results. RESULTS: Of 277 patients with stroke, 105 (38.0%) were COVID-19-positive. Compared with COVID-19-negative patients, COVID-19-positive patients were more likely to have a cryptogenic (51.8% versus 22.3%, P<0.0001) stroke cause and were more likely to suffer ischemic stroke in the temporal (P=0.02), parietal (P=0.002), occipital (P=0.002), and cerebellar (P=0.028) regions. In COVID-19-positive patients, mean coagulation markers were slightly elevated (prothrombin time 15.4±3.6 seconds, partial thromboplastin time 38.6±24.5 seconds, and international normalized ratio 1.4±1.3). Outcomes were worse among COVID-19-positive patients, including longer length of stay (P<0.0001), greater percentage requiring intensive care unit care (P=0.017), and greater rate of neurological worsening during admission (P<0.0001); additionally, more COVID-19-positive patients suffered in-hospital death (33% versus 12.9%, P<0.0001). CONCLUSIONS: Baseline characteristics in patients with stroke were similar comparing those with and without COVID-19. However, COVID-19-positive patients were more likely to experience stroke in a lobar location, more commonly had a cryptogenic cause, and had worse outcomes.

Medical Subject Headings

Adult; Aged; Aged, 80 and over; COVID-19 (complications); Female; Humans; Incidence; Male; Middle Aged; New York City (epidemiology); Risk Factors; SARS-CoV-2; Stroke (epidemiology); Treatment Outcome

Publication Date

1-1-2021

Publication Title

Stroke

E-ISSN

1524-4628

Volume

52

Issue

1

First Page

48

Last Page

56

PubMed ID

33280551

Digital Object Identifier (DOI)

10.1161/STROKEAHA.120.031668

Share

COinS